Manufacturing: Page 34
-
Boehringer to invest $217M in manufacturing build-out at CA site
The German drugmaker's upgrade and expansion to its biologics facility in Fremont will add almost 300 new jobs.
By Suzanne Elvidge • July 26, 2017 -
GSK to ax hundreds of jobs through manufacturing shuffle
The big pharma plans to outsource some of the work at its facility in Worthing, as well as sell off the Horlicks brand of malted milk drinks in the U.K.
By Jacob Bell • July 20, 2017 -
Case study: How a trade deal will affect pharma R&D, supply chains
Canada's recent drug patent reform shows how modern trade deals go beyond tariff reduction to push for regulatory changes that benefit certain industries.
By Edwin Lopez • July 20, 2017 -
Novartis touts manufacturing efforts after restructuring
Everything from R&D to production has benefited from the Swiss pharma reconfiguring its organization last year.
By Lisa LaMotta • July 20, 2017 -
BiondVax grows vaccine production with new facility
The Israeli drugmaker plans to use the nearly 20,000-square-foot space to manufacture its experimental universal flu vaccine.
By Jacob Bell • July 19, 2017 -
Amid supply shortage, FDA clears import of in-demand drug
Athenex, Inc. will be allowed to import sodium bicarbonate 8.4% injection from an Australian manufacturer as supply of the critical drug continues to run dry.
By Ned Pagliarulo • July 13, 2017 -
German Merck axes 200 jobs in production consolidation
In a drive towards efficiency, Merck KGaA is shuffling sites in Europe.
By Suzanne Elvidge • July 13, 2017 -
Vistin hands partner its opioid, CMO businesses
The move will make the Norwegian drugmaker a pure-play developer of metformin for diabetes treatment.
By Jacob Bell • July 13, 2017 -
Manufacturing problems once again stall Ocular's Dextenza
The eye drug developer received another complete response letter for its post-surgical pain treatment.
By Jacob Bell • July 12, 2017 -
Novo Nordisk recalls six batches of insulin cartridge holders
Affected holders could crack or break when exposed to certain chemicals, leading to delivery of lower insulin doses, the Danish drugmaker said.
By Ned Pagliarulo • July 6, 2017 -
GSK taps suppliers, Schneider to meet emission targets
The British drugmaker aims to be carbon neutral by 2050 and will need help from its hundreds of suppliers to help cut down on emissions.
By Edwin Lopez • July 6, 2017 -
FDA issues warning letter to Chinese heparin maker
The agency cited issues with the system suitability and data controls — among other things — at the Shandong Analysis and Test Center.
By Jacob Bell • July 6, 2017 -
Oxford BioMedica, Novartis link up on CAR-T drug production
The deal could provide more than $100 million to the U.K.-based gene therapy developer as well as long-term profitability, according to analysts.
By Jacob Bell • July 6, 2017 -
Pfizer to open new R&D facility in Missouri
The new site is one part of Pfizer's push to improve its manufacturing network, which has been dogged with legacy issues inherited from the acquisition of Hospira.
By Barbara Boughton • June 29, 2017 -
Patheon maps out $45M investment in services network
The Dutch CDMO is in the midst of being acquired by Thermo Fisher for $7.2 billion.
By Ned Pagliarulo • June 29, 2017 -
Janssen gets EU nod for continuous manufacturing
European regulators have OK'd use of an HIV drug made through continuous manufacturing at a site in Puerto Rico.
By Jacob Bell • June 29, 2017 -
Chemicals giant BASF builds out ibuprofen API production
About $230 million will be put toward constructing a new plant in Germany and expanding an existing site in Texas.
By Ned Pagliarulo • June 29, 2017 -
Coherus cuts staff after FDA red light
The California-based company will lay off employees after getting handed a rejection from the FDA for its Neulasta biosimilar.
By Lisa LaMotta • June 28, 2017 -
Takeda set to open new German manufacturing facilities
Construction on the €100 million expansion has wrapped, adding new capacity to the Japanese drugmaker's Oranienburg site.
By Ned Pagliarulo • June 22, 2017 -
BMS sells Irish manufacturing facility to SK Biotek
The Korean drugmaker intends to operate the small molecule production site as a stand-alone CDMO.
By Barbara Boughton • June 21, 2017 -
Sponsored by World Courier
Expect the unexpected: Six potential logistics challenges
Conditions along shipping routes can change with little to no prior warning; prepare for unforeseen circumstances to ensure pharmaceuticals are not at risk.
June 20, 2017 -
FDA
Hospira recalls add to drug shortages
The Pfizer subsidiary is recalling a number of drug products, potentially exacerbating drug shortages for key products like injectable sodium bicarbonate solution.
By Suzanne Elvidge • June 19, 2017 -
Bristol-Myers Squibb recalls mislabeled Eliquis medications
One lot of the blood thinner Eliquis distributed nationwide included bottles with 2.5 mg tablets, mislabeled as Eliquis 5 mg.
By Barbara Boughton • June 15, 2017 -
BioMarin secures FDA approval for Ireland production facility
The Shanbally, Cork site is now cleared for bulk production of a key ingredient for Vimizim, a fast-growing product for the rare disease drugmaker.
By Ned Pagliarulo • June 15, 2017 -
New deal should help Baxter speed up generic injectables development
The agreement with Dorizoe Lifesciences covers more than 20 treatments for cancer, cardiovascular disease or infections.
By Jacob Bell • June 15, 2017
Previous
